Preparation and method for improving stem cell repair capability

By combining Y-27632 and drosophilin A in skin stem cell culture, the culture medium is optimized, which significantly improves the proliferation and migration ability of skin stem cells, solves the problem of insufficient repair ability of skin stem cells in the existing technology, and achieves faster Healing and more effective therapeutic effects.

CN118979008APending Publication Date: 2024-11-19SHANDONG FIRST MEDICAL UNIV & SHANDONG ACADEMY OF MEDICAL SCI +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410948779.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-16
Publication Date
2024-11-19

AI Technical Summary

Technical Problem

In the prior art, skin stem cells alone are not able to migrate and proliferate quickly when repairing skin lesions, and Y-27632 has limited proliferation effect, and high concentrations of use may have adverse effects on stem cells. Dracophne A is in stem cells. The combined application in culture has not been studied in depth.

Method used

A preparation including basal culture medium, human platelet lysates, Y-27632 and dracocin A was used to optimize the cell culture environment, with a final concentration of 10 ng/mL Y-27632 and 10-20 μg/mL dracocin A , the proliferation and migration ability of skin stem cells is significantly improved through this preparation, and is suitable for the treatment of skin lesions.

Benefits of technology

It significantly improves the repair ability of skin stem cells, shortens healing time, improves the therapeutic effect, avoids the adverse effects of high concentrations of drugs on stem cells, and provides a more efficient and safe treatment plan.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118979008A_ABST
    Figure CN118979008A_ABST
Patent Text Reader

Abstract

The invention belongs to the technical field of biology, and particularly relates to a preparation and a method for improving stem cell repair capability. The preparation is prepared from a basic culture medium, a human platelet lysate, Y-27632 and loureirin A. By optimizing the concentration combination of Y-27632 and loureirin A, the proliferation ability and migration ability of the human skin stem cells are remarkably improved, so that the effect of the human skin stem cells in tissue repair is enhanced. Y-27632 and loureirin A are jointly applied to stem cell culture for the first time, it is found that Y-27632 and loureirin A have a synergistic promotion effect, and the repairing capacity of skin stem cells is far higher than the effect of single use of any component. Meanwhile, the preparation and the method can be widely applied to the fields of skin injury treatment, tissue regeneration medicine and the like, and have important scientific significance and wide application prospects.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of biological technology, and in particular relates to a preparation and method for improving the repair ability of stem cells. Background Art

[0002] Skin is the largest organ in the human body and has many important functions, including protection, temperature regulation and sensation. Skin injuries, including burns, trauma, surgical incisions and ulcers, often lead to serious functional disorders and aesthetic problems. Although traditional skin repair methods, such as autologous skin transplantation, artificial skin and various drug treatments, can promote skin regeneration and repair to a certain extent, they still have many limitations, such as insufficient donor skin, immune rejection, slow healing and functional and aesthetic deficiencies.

[0003] In recent years, stem cell therapy has shown great potential in the field of skin damage repair. Skin stem cells (such as skin stem cells and hair follicle stem cells) have become a hot topic of research due to their self-renewal and multidirectional differentiation capabilities. However, in practical applications, the effect of using skin stem cells alone to repair skin damage is still not ideal. The main reasons are that stem cells have insufficient migration ability after transplantation, insufficient proliferation rate, and limited angiogenesis ability. Therefore, effectively improving the repair ability of stem cells is a problem that needs to be solved at present.

[0004] Y-27632 is a highly effective Rho-associated coiled-coil protein kinase (ROCK) inhibitor, CAS146986-50-7. Y-27632 affects various cellular processes such as cytoskeleton reorganization, cell movement, proliferation and apoptosis by inhibiting the activity of two isozymes, ROCK1 and ROCK2. In the patent "Application of Y-27632 in Mesenchymal Stem Cell Culture and Method for Cultivating Mesenchymal Stem Cells" (Application No.: 201510288527.3), the inventors found that Y-27632 can effectively promote the proliferation ability of mesenchymal stem cells. However, its overall pro-proliferation effect is relatively limited, and it can only increase the proliferation rate by about 30%. Further increasing the concentration of Y-27632 may have an adverse effect on the stemness of stem cells. Therefore, how to better optimize the pro-proliferation effect of Y-27632 when using it has become an important issue that needs to be solved at present.

[0005] Dracorhodin Perchlorate is a flavonoid isolated from the dragon's blood tree, CAS119425-89-7. Dracorhodin Perchlorate has attracted attention for its multiple pharmacological activities in the field of traditional Chinese medicine, and has multiple biological effects such as anti-inflammatory, antioxidant, anti-tumor, and antibacterial. In terms of stem cells, only a small amount of literature shows that Dracorhodin Perchlorate can regulate the proliferation of hair follicle stem cells. However, the prior art has not seen any reports on the combined application of Dracorhodin Perchlorate and Y-27632 in stem cell culture or other biological research. Although the two show significant biological activity in their respective fields, the synergistic effect that may be brought about by their combined use has not yet been deeply studied and verified. Summary of the invention

[0006] The present invention provides a preparation and method for improving the repair ability of stem cells, thereby effectively improving the repair ability of stem cells and better exerting the repair effect of stem cells.

[0007] To achieve the above object, the present invention provides the following technical solutions:

[0008] In a first aspect, the present invention provides a preparation for improving the repair ability of stem cells, the preparation comprising a basal culture medium, human platelet lysate, Y-27632 and Loureirin A.

[0009] Preferably, the final concentration of Y-27632 in the preparation is 10 ng / mL, and the final concentration of Loreerain A is 10-20 μg / mL.

[0010] Preferably, the stem cells are human skin stem cells, and the basal culture medium is α-MEM basal culture medium.

[0011] This preparation significantly improves the proliferation and migration ability of human skin stem cells by optimizing the cell culture environment, thereby enhancing their effect in tissue repair. It is particularly suitable for the treatment of skin injuries such as burns, trauma, surgical incisions and ulcers.

[0012] In a second aspect, the present invention provides a method for improving the repair ability of stem cells, characterized in that the method comprises the following steps:

[0013] (1) selecting cultured P3-P6 stem cells, discarding the original culture medium, washing and digesting the cells;

[0014] (2) adding α-MEM basal medium containing 10% human platelet lysate to terminate digestion, centrifuging, and preparing a cell suspension;

[0015] (3) Add the cell suspension to the culture flask, and place the inoculated culture flask in a 37°C, 5% CO2 incubator for culture;

[0016] (4) Cultivate until the cells reach 70-85% confluence, discard the culture medium, and add induction medium;

[0017] (5) The culture flask was returned to the incubator at 37°C and 5% CO2 for 3 days of induction culture to obtain stem cells with enhanced repair ability.

[0018] Preferably, the induction medium consists of α-MEM basal medium, 10% human platelet lysate, 10 ng / mL Y-27632, and 10-20 μg / mL Loureirin A;

[0019] The stem cells are human skin stem cells.

[0020] This method effectively enhances the repair capacity of skin stem cells, can significantly accelerate the healing process of skin damage, reduce healing time, improve treatment effects, and is suitable for various skin repair treatment programs.

[0021] In a third aspect, the present invention provides a use of a combined preparation in preparing a culture medium for improving the repair ability of human skin stem cells, wherein the combined preparation consists of Y-27632 and Loureirin A;

[0022] In the culture medium, the final concentration of Y-27632 is 10 ng / mL, and the final concentration of Loire's blood A is 10-20 μg / mL.

[0023] Preferably, the culture medium further comprises: α-MEM basal medium and 10% human platelet lysate;

[0024] The combined preparation improves the repairing ability of human skin stem cells by improving the proliferation ability and migration ability of human skin stem cells.

[0025] This application is of great significance in regenerative medicine and skin damage repair, and can effectively enhance the therapeutic effect of stem cells, shorten recovery time, and improve the quality of life of patients.

[0026] In a fourth aspect, the present invention provides a use of a combined preparation in preparing a culture medium for improving the proliferation ability of human skin stem cells, wherein the combined preparation consists of Y-27632 and Loureirin A;

[0027] In the culture medium, the final concentration of Y-27632 is 10 ng / mL, and the final concentration of dragon's blood A is 10-20 μg / mL;

[0028] The culture medium further comprises: α-MEM basic culture medium and 10% human platelet lysate.

[0029] By improving the proliferation capacity of skin stem cells, this combination preparation can be widely used in the fields of tissue engineering and regenerative medicine, providing a more effective solution for skin damage repair.

[0030] In a fifth aspect, the present invention provides a use of a combined preparation in preparing a culture medium for improving the migration ability of human skin stem cells, wherein the combined preparation consists of Y-27632 and Loureirin A;

[0031] In the culture medium, the final concentration of Y-27632 is 10 ng / mL, and the final concentration of dragon's blood A is 10-20 μg / mL;

[0032] The culture medium further comprises: α-MEM basic culture medium and 10% human platelet lysate.

[0033] By improving the migration ability of skin stem cells, the cell colonization and tissue repair process at the damaged site can be accelerated, significantly improving the treatment effect, and the application prospects are broad.

[0034] In a sixth aspect, the present invention provides an application of a combined preparation in the preparation of a medicament for treating skin damage, characterized in that the combined preparation consists of 10 ng / mL Y-27632 and 10-20 μg / mL dragon's blood A.

[0035] The combined preparation can significantly accelerate the healing process of skin injuries, reduce complications, and improve the quality of healing in clinical applications, and has important clinical significance and application value.

[0036] The beneficial effect of the present invention is that, for the first time, Y-27632 and Loureirin A are used in combination in stem cell culture. Experimental results show that the combination of the two significantly improves the proliferation ability of skin stem cells, and at the same time significantly improves the migration ability of skin stem cells, allowing cells to colonize more quickly at the site of injury, thereby accelerating the repair process. By using the combination, the repair ability of skin stem cells is much higher than that of using either component alone, providing a more efficient treatment plan.

[0037] Secondly, by optimizing the concentrations of Y-27632 and Loureirin A, the present invention can improve cell function while avoiding the adverse effects of high-concentration drugs on the stemness of stem cells, thereby improving the safety and effectiveness of treatment.

[0038] In addition, the preparation and method of the present invention are not only applicable to skin stem cells, but can also be extended to other types of stem cell repair treatments, and have broad application prospects. BRIEF DESCRIPTION OF THE DRAWINGS

[0039] Figure 1The effects of the culture methods of Example 3 and Example 4, Comparative Example 5, Comparative Example 6, Comparative Example 7 and Comparative Example 8 on the proliferation capacity of skin stem cells are shown;

[0040] Figure 2 The results of detecting the expression level of Cyclin E1 protein by Western Blot (WB) are shown;

[0041] Figure 3 The effects of the culture methods of Example 3 and Example 4, Comparative Example 5, Comparative Example 6 and Comparative Example 7 on the migration ability of skin stem cells are shown. DETAILED DESCRIPTION

[0042] It should be noted that the following detailed descriptions are exemplary and are intended to provide further explanation of the present application. Unless otherwise expressly indicated, all technical and scientific terms used herein have the same meanings as those commonly understood by those skilled in the art to which the present application belongs.

[0043] In this context, this specification provides specific embodiments and examples to describe the present invention in detail. However, the scope of the present invention is not limited to these specific embodiments and examples. On the contrary, the scope of the present invention encompasses all equivalents and modifications that fall within the scope of the appended claims.

[0044] Example 1

[0045] An induction culture medium for improving the repair ability of skin stem cells

[0046] The induction medium consists of the following components: α-MEM basal medium, 10% human platelet lysate, 10 ng / mL LY-27632, and 10 μg / mL Loureirin A.

[0047] The preparation method of the induction culture medium comprises the following steps: adding Y-27632 and Loureirin A into an α-MEM basic culture medium so that the final concentrations thereof are 10 ng / mL and 10 μg / mL respectively, and filtering and sterilizing the culture medium.

[0048] 10% volume of human platelet lysate was added and mixed evenly to obtain the induction medium.

[0049] Example 2

[0050] An induction culture medium for improving the repair ability of skin stem cells

[0051] The induction medium consists of the following components: α-MEM basal medium, 10% human platelet lysate, 10 ng / mL LY-27632, and 20 μg / mL Loureirin A.

[0052] The preparation method of the induction culture medium comprises the following steps: adding Y-27632 and Loureirin A into an α-MEM basic culture medium so that the final concentrations thereof are 10 ng / mL and 10 μg / mL respectively, and filtering and sterilizing the culture medium.

[0053] 10% volume of human platelet lysate was added and mixed evenly to obtain the induction medium.

[0054] Comparative Example 1

[0055] Normal skin stem cell culture medium

[0056] The common skin stem cell culture medium consists of the following components: α-MEM basic culture medium and 10% human platelet lysate.

[0057] The preparation method is the same as that of Example 1.

[0058] Comparative Example 2

[0059] Single-ingredient skin stem cell induction medium

[0060] The induction medium consists of the following components: α-MEM basal medium, 10% human platelet lysate, and 10 ng / mL LY-27632.

[0061] The preparation method is the same as that of Example 1.

[0062] Comparative Example 3

[0063] Single-ingredient skin stem cell induction medium

[0064] The induction medium consists of the following components: α-MEM basal medium, 10% human platelet lysate, and 10 μg / mL Loureirin A.

[0065] The preparation method is the same as that of Example 1.

[0066] Comparative Example 4

[0067] Single-ingredient skin stem cell induction medium

[0068] The induction medium consists of the following components: α-MEM basal medium, 10% human platelet lysate, and 20 μg / mL Loureirin A.

[0069] The preparation method is the same as that of Example 1.

[0070] Example 3

[0071] A method for improving the repair ability of skin stem cells

[0072] Human skin stem cells from P3-P6 (the present invention selects P3 generation cells) are selected for the experiment

[0073] 1) The culture medium in the P3 skin stem cell culture flask was aspirated and discarded, the cells were washed with PBS buffer, and then the cells were completely covered with trypsin-EDTA solution.

[0074] 2) Digest in a 37°C incubator until the cells begin to fall off, add α-MEM basal medium containing 10% human platelet lysate, gently blow the bottom of the culture flask to completely detach the cells, and transfer the cells to a centrifuge tube.

[0075] 3) Centrifuge at 1000 rpm for 5 minutes, discard the supernatant, add α-MEM basal medium containing 10% human platelet lysate to resuspend the cells to prepare a cell suspension.

[0076] 4) Add the cell suspension into the culture flask, and place the inoculated culture flask in a 37° C., 5% CO 2 incubator for culture.

[0077] 5) Cultivate until the cells reach a confluence of 70-85%, discard the old culture medium, and add the induction medium prepared in Example 1.

[0078] 6) The culture flask was returned to the incubator at 37° C. and 5% CO 2 for further culture. After 3 days of induction culture, human skin stem cells with enhanced repair ability were obtained.

[0079] Example 4

[0080] A method for improving the repair ability of skin stem cells

[0081] Human skin stem cells from P3-P6 (the present invention selects P3 generation cells) are selected for the experiment

[0082] 1) The culture medium in the P3 skin stem cell culture flask was aspirated and discarded, the cells were washed with PBS buffer, and then the cells were completely covered with trypsin-EDTA solution.

[0083] 2) Digest in a 37°C incubator until the cells begin to fall off, add α-MEM basal medium containing 10% human platelet lysate, gently blow the bottom of the culture flask to completely detach the cells, and transfer the cells to a centrifuge tube.

[0084] 3) Centrifuge at 1000 rpm for 5 minutes, discard the supernatant, add α-MEM basal medium containing 10% human platelet lysate to resuspend the cells to prepare a cell suspension.

[0085] 4) Add the cell suspension into the culture flask, and place the inoculated culture flask in a 37° C., 5% CO 2 incubator for culture.

[0086] 5) Cultivate until the cells reach a confluence of 70-85%, discard the old culture medium, and add the induction medium prepared in Example 2.

[0087] 6) The culture flask was returned to the incubator at 37° C. and 5% CO 2 for further culture. After 3 days of induction culture, human skin stem cells with enhanced repair ability were obtained.

[0088] Comparative Example 5

[0089] 1) The culture medium in the P3 skin stem cell culture flask was aspirated and discarded, the cells were washed with PBS buffer, and then the cells were completely covered with trypsin-EDTA solution.

[0090] 2) Digest in a 37°C incubator until the cells begin to fall off, add α-MEM basal medium containing 10% human platelet lysate, gently blow the bottom of the culture flask to completely detach the cells, and transfer the cells to a centrifuge tube.

[0091] 3) Centrifuge at 1000 rpm for 5 minutes, discard the supernatant, add α-MEM basal medium containing 10% human platelet lysate to resuspend the cells to prepare a cell suspension.

[0092] 4) Add the cell suspension into the culture flask, and place the inoculated culture flask in a 37° C., 5% CO 2 incubator for culture.

[0093] 5) Cultivate until the cells reach a confluence of 70-85%, discard the old culture medium, and add the common skin stem cell culture medium in Comparative Example 1.

[0094] 6) The culture flask was returned to the incubator at 37° C. and 5% CO 2 for further culture. After 3 days of induction culture, human skin stem cells with enhanced repair ability were obtained.

[0095] Comparative Example 6

[0096] 1) The culture medium in the P3 skin stem cell culture flask was aspirated and discarded, the cells were washed with PBS buffer, and then the cells were completely covered with trypsin-EDTA solution.

[0097] 2) Digest in a 37°C incubator until the cells begin to fall off, add α-MEM basal medium containing 10% human platelet lysate, gently blow the bottom of the culture flask to completely detach the cells, and transfer the cells to a centrifuge tube.

[0098] 3) Centrifuge at 1000 rpm for 5 minutes, discard the supernatant, add α-MEM basal medium containing 10% human platelet lysate to resuspend the cells to prepare a cell suspension.

[0099] 4) Add the cell suspension into the culture flask, and place the inoculated culture flask in a 37° C., 5% CO 2 incubator for culture.

[0100] 5) Cultivate until the cells reach a confluence of 70-85%, discard the old culture medium, and add the single-component skin stem cell induction culture medium in Comparative Example 2.

[0101] 6) The culture flask was returned to the incubator at 37° C. and 5% CO 2 for further culture. After 3 days of induction culture, human skin stem cells with enhanced repair ability were obtained.

[0102] Comparative Example 7

[0103] 1) The culture medium in the P3 skin stem cell culture flask was aspirated and discarded, the cells were washed with PBS buffer, and then the cells were completely covered with trypsin-EDTA solution.

[0104] 2) Digest in a 37°C incubator until the cells begin to fall off, add α-MEM basal medium containing 10% human platelet lysate, gently blow the bottom of the culture flask to completely detach the cells, and transfer the cells to a centrifuge tube.

[0105] 3) Centrifuge at 1000 rpm for 5 minutes, discard the supernatant, add α-MEM basal medium containing 10% human platelet lysate to resuspend the cells to prepare a cell suspension.

[0106] 4) Add the cell suspension into the culture flask, and place the inoculated culture flask in a 37° C., 5% CO 2 incubator for culture.

[0107] 5) Cultivate until the cells reach a confluence of 70-85%, discard the old culture medium, and add the single-component skin stem cell induction culture medium in Comparative Example 3.

[0108] 6) The culture flask was returned to the incubator at 37° C. and 5% CO 2 for further culture. After 3 days of induction culture, human skin stem cells with enhanced repair ability were obtained.

[0109] Comparative Example 8

[0110] 1) The culture medium in the P3 skin stem cell culture flask was aspirated and discarded, the cells were washed with PBS buffer, and then the cells were completely covered with trypsin-EDTA solution.

[0111] 2) Digest in a 37°C incubator until the cells begin to fall off, add α-MEM basal medium containing 10% human platelet lysate, gently blow the bottom of the culture flask to completely detach the cells, and transfer the cells to a centrifuge tube.

[0112] 3) Centrifuge at 1000 rpm for 5 minutes, discard the supernatant, add α-MEM basal medium containing 10% human platelet lysate to resuspend the cells to prepare a cell suspension.

[0113] 4) Add the cell suspension into the culture flask, and place the inoculated culture flask in a 37° C., 5% CO 2 incubator for culture.

[0114] 5) Cultivate until the cells reach a confluence of 70-85%, discard the old culture medium, and add the single-component skin stem cell induction culture medium in Comparative Example 4.

[0115] 6) The culture flask was returned to the incubator at 37° C. and 5% CO 2 for further culture. After 3 days of induction culture, human skin stem cells with enhanced repair ability were obtained.

[0116] Experimental Example 1

[0117] Detection of differences in cell proliferation ability of human skin stem cells cultured by different culture methods

[0118] (1) Cells cultured for 3 days using the culture methods of Example 3, Example 4, Comparative Example 5, Comparative Example 6, Comparative Example 7 and Comparative Example 8 were prepared into a cell suspension.

[0119] (2) The cell suspension was inoculated into a 96-well plate at a volume of 5000 cells per well, 100 μL per well, ensuring that the number of cells in each well was consistent, and 5 replicate wells were set for each treatment;

[0120] (3) Place the 96-well plate in an incubator at 37°C and 5% CO2 and continue culturing;

[0121] (4) After 72 h of culture, add 10 μL of CCK-8 reagent to each well. Avoid generating bubbles when adding.

[0122] (5) Place the CCK-8-added reagent back into a 37°C, 5% CO2 incubator and incubate for 2.5 h;

[0123] (6) After incubation, the absorbance of each well was measured at a wavelength of 450 nm using a microplate reader, and the average OD value of each treatment group was calculated.

[0124] Table 1 Average OD values ​​of different treatment groups

[0125]

[0126] Analysis Table 1 and Figure 1 It can be seen that compared with the cells treated with Comparative Example 5, the OD value of Example 3 was 1.255, an increase of 0.542, equivalent to an increase of 76.02%, P < 0.001, and the difference was statistically significant.

[0127] The OD value of Example 4 was 1.340, which increased by 0.627, equivalent to an increase of 87.94%, P < 0.001, and the difference was statistically significant.

[0128] The OD value of comparative example 6 was 0.893, which increased by 0.180, equivalent to an increase of 25.25%, P < 0.001, and the difference was statistically significant.

[0129] The OD value of comparative example 7 was 0.857, which increased by 0.144, equivalent to an increase of 20.20%, P < 0.01, and the difference was statistically significant.

[0130] The OD value of comparative example 8 was 0.926, which increased by 0.213, equivalent to an increase of 29.87%, P < 0.001, and the difference was statistically significant.

[0131] From the above results, it can be seen that compared with Comparative Example 5, pretreatment with culture medium added with Y-27632 or Loureirin A can improve the proliferation ability of skin stem cells to a certain extent, and increasing the concentration of Loureirin A can also enhance the promoting effect on the proliferation ability of skin stem cells.

[0132] For Example 3, which used 10 ng / mL Y-27632 and 10 μg / mL Lu'erhaerin A together, its promoting effect on proliferation ability was 3.01 times that of 10 ng / mL Y-27632 alone, 3.73 times that of 10 μg / mL Lu'erhaerin A alone, and 1.67 times that of the sum of the two. It can be seen that the effect of the combined use of 10 ng / mL Y-27632 and 10 μg / mL Lu'erhaerin A is significantly higher than the theoretical sum effect and the effect of each use, indicating that the combined use of 10 ng / mL Y-27632 and 10 μg / mL Lu'erhaerin A can produce a synergistic promoting effect on the proliferation of skin stem cells.

[0133] For Example 3, which uses 10 ng / mL Y-27632 and 20 μg / mL Lu'erhaerin A together, its promoting effect on proliferation ability is 3.45 times that of 10 ng / mL Y-27632 alone, 2.91 times that of 20 μg / mL Lu'erhaerin A alone, and 1.57 times that of the sum of the two. It can be seen that the effect of the combined use of 10 ng / mL Y-27632 and 10 μg / mL Lu'erhaerin A is significantly higher than the theoretical sum effect and the effect of the combined use of each, indicating that the combined use of 10 ng / mL Y-27632 and 20 μg / mL Lu'erhaerin A can also produce a synergistic promoting effect on the proliferation of skin stem cells.

[0134] Experimental Example 2

[0135] In order to further study the promoting effect of the combination of Y-27632 and Loureirin A on the proliferation of skin stem cells, the present invention detects the protein expression of Cyclin E1, a core protein of cell proliferation.

[0136] (1) Cell lysis:

[0137] Skin stem cells pre-cultured for 3 days according to the culture methods of Example 3, Comparative Example 5, Comparative Example 6 and Comparative Example 7 were collected, and the cells were lysed using RIPA lysis buffer (containing protease and phosphatase inhibitors).

[0138] The mixture was incubated on ice for 30 min, vortexed gently every 10 min, and centrifuged at 12,000 rpm for 10 min to collect the supernatant.

[0139] (2) Protein quantification:

[0140] The protein concentration was determined using the BCA protein quantification kit.

[0141] (3) Electrophoresis and membrane transfer

[0142] Add 5× SDS-PAGE loading buffer to the protein sample, boil for 5 minutes and then cool on ice.

[0143] The protein samples were loaded into SDS-PAGE gel and the proteins were separated by electrophoresis at a constant voltage of 90 and 120 V until the dye front reached the bottom of the gel.

[0144] After activating the PVDF membrane with methanol, the protein was transferred from the gel to the membrane at 4°C and 100V for 1.5 hours.

[0145] (4) Closure:

[0146] The membrane was blocked in 5% nonfat dry milk in TBST buffer for 1 hour at room temperature to block nonspecific binding.

[0147] (5) Primary antibody incubation

[0148] The membrane was incubated with primary antibodies against Cyclin E1 and β-actin at 4 °C overnight.

[0149] (6) Secondary antibody incubation

[0150] Wash the membrane three times with TBST buffer, 10 min each time.

[0151] Incubate with HRP-conjugated secondary antibody at room temperature for 1 hour.

[0152] (7) Detection and imaging

[0153] Wash the membrane three times with TBST buffer, 10 min each time.

[0154] After the membrane was incubated in ECL luminescent substrate, the chemiluminescent system was used for detection and photography.

[0155] The results are as follows Figure 2 As shown, similar to the results of the CCK-8 experiment, the protein expression level of Cyclin E1 in the cells treated with Comparative Examples 6 and 7 was higher than that in the cells treated with Comparative Example 5, which is consistent with the results of the CCK-8 experiment.

[0156] It can be further seen that the expression level of Cyclin E1 in the cells treated with Example 3 is significantly higher than that in the cells treated with Comparative Example 5, and is also significantly higher than that in the cells treated with Comparative Examples 6 and 7, which is consistent with the results of the CCK-8 experiment.

[0157] Therefore, the results of the WB experiment further verified that the combination of Y-27632 and dragon's blood A can synergistically promote the proliferation ability of skin stem cells.

[0158] Example 3

[0159] After detecting that the combination of Y-27632 and Loureirin A can synergistically promote the proliferation of skin stem cells, the present invention uses a Transwell chamber to detect the effect of the combination of the two on the migration of skin stem cells.

[0160] (1) Cell preparation

[0161] The human skin stem cells pre-cultured for 3 days according to the culture methods of Example 3, Comparative Example 5, Comparative Example 6 and Comparative Example 7 were collected, centrifuged at 1000 rpm for 5 minutes, and the supernatant was discarded.

[0162] Resuspend the cells in serum-free medium and adjust the cell concentration to 1×10^6 cells per ml.

[0163] (2) Pretreatment of Transwell chamber

[0164] Add 100 μL of serum-free medium to the upper chamber of each Transwell chamber, and add 600 μL of medium containing 10% FBS to the lower chamber.

[0165] The cells were equilibrated in a 37°C, 5% CO2 incubator for 30 minutes, and the pre-equilibration medium was subsequently discarded.

[0166] (3) Cell seeding

[0167] Add 100 μL of cell suspension (approximately 1×10^5 cells per well) to the upper chamber of each Transwell chamber.

[0168] Add 600 μL of α-MEM basal medium containing 10% FBS to the lower chamber as an inducer of cell migration.

[0169] (4) Cell culture

[0170] The Transwell chamber was placed in a 37°C, 5% CO2 incubator and incubated for 24 hours.

[0171] (5) Fixed

[0172] After the incubation, carefully remove the Transwell chamber and gently wipe off the unmigrated cells in the upper chamber with a cotton swab.

[0173] After washing twice with cold PBS, the Transwell chamber was fixed by immersion in methanol for 15 minutes.

[0174] After fixation, the sections were washed twice in PBS.

[0175] (6) Dyeing

[0176] The Transwell chamber was immersed in the stain for 20 minutes and then washed three times with PBS to remove unbound dye.

[0177] (7) Counting migrating cells

[0178] The filter membrane in the lower chamber of the Transwell chamber was observed under a microscope, and 6 fields of view were randomly selected to count the number of migrated cells.

[0179] (8) Calculation of relative mobility

[0180] The average number of migrated cells in each sample was compared with that in the control group (Comparative Example 5), and the relative migration rate of each treatment group was calculated.

[0181] The results are shown in Table 2 and Figure 3 As shown:

[0182] Table 2 Average cell migration number and relative migration rate

[0183] Experimental treatment groups Average number of cell migration Relative mobility Comparative Example 5 92 100.0% Comparative Example 6 109 118.4% Example 3 152 165.2% Comparative Example 7 117 126.8%

[0184] Table 2 and Figure 3 The data showed that compared with the cells pre-cultured by the method of comparative example 5, the cells pre-cultured by the methods of comparative example 6 and comparative example 7 showed stronger migration ability. Among them, the migration ability of the cells pre-cultured by the method of comparative example 7 was significantly better than that of the cells pre-cultured by the method of comparative example 6. This shows that in promoting cell migration, the effect of Lu'er's blood A is better than that of Y-27632.

[0185] Further analysis revealed that the number and migration rate of cells cultured by the method of Example 3 were significantly improved compared to the cells pre-cultured by the methods of Comparative Examples 5, 6 and 7. Specifically, the promoting effect of Y-27632 and Lure's Blood A on cell migration (65.2%) was 3.54 times that of Y-27632 alone (18.4%), 2.43 times that of Lure's Blood A alone, and 1.44 times the theoretical promoting effect of the combined effects of the two alone.

[0186] These results show that the combination of Y-27632 and Loureirin A has a synergistic effect on the migration of skin stem cells. This synergistic effect significantly enhances the migration ability of cells, indicating that the combination of drugs is of great significance in cell migration research and potential clinical applications. By optimizing the combined use of the two, the migration efficiency of skin stem cells can be significantly improved, providing a more effective solution for tissue repair and regenerative medicine.

Claims

1. A preparation for improving the repair ability of stem cells, characterized in that: The preparation includes basal culture medium, human platelet lysate, Y-27632 and Loureirin A.

2. A preparation for improving the repair ability of stem cells according to claim 1, characterized in that: The final concentration of Y-27632 in the preparation is 10 ng / mL, and the final concentration of Loreerain A is 10-20 μg / mL.

3. A preparation for improving the repair ability of stem cells according to claim 2, characterized in that: The stem cells are human skin stem cells, and the basal culture medium is α-MEM basal culture medium.

4. A method for improving the repair ability of stem cells, characterized in that: The method comprises the following steps: (1) selecting cultured P3-P6 stem cells, discarding the original culture medium, washing and digesting the cells; (2) adding α-MEM basal medium containing 10% human platelet lysate to terminate digestion, centrifuging, and preparing a cell suspension; (3) Add the cell suspension to the culture flask, and place the inoculated culture flask in a 37°C, 5% CO2 incubator for culture; (4) Cultivate until the cells reach 70-85% confluence, discard the culture medium, and add induction medium; (5) The culture flask was returned to the incubator at 37°C and 5% CO2 for 3 days of induction culture to obtain stem cells with enhanced repair ability.

5. A method for improving the repair ability of stem cells according to claim 4, characterized in that: The induction medium consists of α-MEM basal medium, 10% human platelet lysate, 10 ng / mL Y-27632, and 10-20 μg / mL Loureirin A; The stem cells are human skin stem cells.

6. Use of a combined preparation in preparing a culture medium for improving the repair ability of human skin stem cells, characterized in that: The combined preparation consists of Y-27632 and Loureirin A; In the culture medium, the final concentration of Y-27632 is 10 ng / mL, and the final concentration of Loire's blood A is 10-20 μg / mL.

7. Use of a combined preparation according to claim 6 in preparing a culture medium for improving the repair ability of human skin stem cells, characterized in that: The culture medium also includes: α-MEM basic culture medium and 10% human platelet lysate; The combined preparation improves the repairing ability of human skin stem cells by improving the proliferation ability and migration ability of human skin stem cells.

8. Use of a combined preparation in preparing a culture medium for improving the proliferation ability of human skin stem cells, characterized in that: The combined preparation consists of Y-27632 and Loureirin A; In the culture medium, the final concentration of Y-27632 is 10 ng / mL, and the final concentration of dragon's blood A is 10-20 μg / mL; The culture medium further comprises: α-MEM basic culture medium and 10% human platelet lysate.

9. Use of a combined preparation in preparing a culture medium for improving the migration ability of human skin stem cells, characterized in that: The composition preparation consists of Y-27632 and Loreerain A; In the culture medium, the final concentration of Y-27632 is 10 ng / mL, and the final concentration of dragon's blood A is 10-20 μg / mL; The culture medium further comprises: α-MEM basic culture medium and 10% human platelet lysate.

10. Use of a combined preparation in the preparation of a drug for treating skin damage, characterized in that: The combination formulation consisted of 10 ng / mL Y-27632 and 10-20 μg / mL Loureirin A.